Vanguard Group »

Catalyst Pharmaceutical Partners shares owned by Vanguard Group

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Vanguard Group

Quarter filed Position value Share count Share price at filing
2013-03-31 $203k 414k 0.49
2012-12-31 $71k 162k 0.44
2012-09-30 $244k 162k 1.51
2012-03-31 $107k 96k 1.11
2011-09-30 $142k 96k 1.48
2011-06-30 $143k 76k 1.89
2011-03-31 $78k 70k 1.12

More positions owned by Vanguard Group

Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
UnitedHealth (UNH)
Eli Lilly & Co. (LLY)
Exxon Mobil Corporation (XOM)
Visa Com Cl A (V)

View all positions for Vanguard Group

Top funds holding Catalyst Pharmaceutical Partners

Deerfield Management Company
Vanguard Group
Dimensional Fund Advisors
Royce & Associates
Robeco Investment Management
Jacobs Levy Equity Management
Opaleye Management
LSV Asset Management
T. Rowe Price Associates
Henderson Group
Goldman Sachs Group
Charles Schwab Investment Management
Jupiter Asset Management
Bank of New York Mellon
Bank of America Corporation

View all funds holding Catalyst Pharmaceutical Partners